150 related articles for article (PubMed ID: 12929194)
1. Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion.
Gosselin LE; Barkley JE; Spencer MJ; McCormick KM; Farkas GA
Muscle Nerve; 2003 Sep; 28(3):336-43. PubMed ID: 12929194
[TBL] [Abstract][Full Text] [Related]
2. Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice.
Stupka N; Michell BJ; Kemp BE; Lynch GS
Neuromuscul Disord; 2006 May; 16(5):337-46. PubMed ID: 16621557
[TBL] [Abstract][Full Text] [Related]
3. Inspiratory pressure-generating capacity is preserved during ventilatory and non-ventilatory behaviours in young dystrophic mdx mice despite profound diaphragm muscle weakness.
Burns DP; Murphy KH; Lucking EF; O'Halloran KD
J Physiol; 2019 Feb; 597(3):831-848. PubMed ID: 30570134
[TBL] [Abstract][Full Text] [Related]
4. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
Yuasa K; Nakamura A; Hijikata T; Takeda S
BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
[TBL] [Abstract][Full Text] [Related]
5. Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice.
Piers AT; Lavin T; Radley-Crabb HG; Bakker AJ; Grounds MD; Pinniger GJ
Neuromuscul Disord; 2011 Feb; 21(2):132-41. PubMed ID: 21055937
[TBL] [Abstract][Full Text] [Related]
6. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
Radley HG; Davies MJ; Grounds MD
Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
[TBL] [Abstract][Full Text] [Related]
7. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.
Hnia K; Hugon G; Rivier F; Masmoudi A; Mercier J; Mornet D
Am J Pathol; 2007 Feb; 170(2):633-43. PubMed ID: 17255331
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
9. Targeting the immune system to improve ventilatory function in muscular dystrophy.
Gosselin LE; McCormick KM
Med Sci Sports Exerc; 2004 Jan; 36(1):44-51. PubMed ID: 14707767
[TBL] [Abstract][Full Text] [Related]
10. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
Hodgetts S; Radley H; Davies M; Grounds MD
Neuromuscul Disord; 2006 Oct; 16(9-10):591-602. PubMed ID: 16935507
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
Gosselin LE; Williams JE
Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine treatment reduces TNF-α levels and myonecrosis in diaphragm muscle of mdx mice.
de Senzi Moraes Pinto R; Ferretti R; Moraes LH; Neto HS; Marques MJ; Minatel E
Clin Nutr; 2013 Jun; 32(3):472-5. PubMed ID: 22727548
[TBL] [Abstract][Full Text] [Related]
13. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.
Shavlakadze T; White J; Hoh JF; Rosenthal N; Grounds MD
Mol Ther; 2004 Nov; 10(5):829-43. PubMed ID: 15509501
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle.
Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ
Hum Mol Genet; 2006 May; 15(9):1423-35. PubMed ID: 16551657
[TBL] [Abstract][Full Text] [Related]
15. Regenerative capacity of the dystrophic (mdx) diaphragm after induced injury.
Matecki S; Guibinga GH; Petrof BJ
Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R961-8. PubMed ID: 15191902
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid decreases TNF-α and protects dystrophic muscles of mdx mice from degeneration.
Machado RV; Mauricio AF; Taniguti AP; Ferretti R; Neto HS; Marques MJ
J Neuroimmunol; 2011 Mar; 232(1-2):145-50. PubMed ID: 21131061
[TBL] [Abstract][Full Text] [Related]
17. Mdx respiratory impairment following fibrosis of the diaphragm.
Ishizaki M; Suga T; Kimura E; Shiota T; Kawano R; Uchida Y; Uchino K; Yamashita S; Maeda Y; Uchino M
Neuromuscul Disord; 2008 Apr; 18(4):342-8. PubMed ID: 18358722
[TBL] [Abstract][Full Text] [Related]
18. Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP.
Doran P; Martin G; Dowling P; Jockusch H; Ohlendieck K
Proteomics; 2006 Aug; 6(16):4610-21. PubMed ID: 16835851
[TBL] [Abstract][Full Text] [Related]
19. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S
Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298
[TBL] [Abstract][Full Text] [Related]
20. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.
Kuru S; Inukai A; Kato T; Liang Y; Kimura S; Sobue G
Acta Neuropathol; 2003 Mar; 105(3):217-24. PubMed ID: 12557007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
